These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23483363)

  • 1. A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells.
    Korell J; Stamp LK; Barclay ML; Dalrymple JM; Drake J; Zhang M; Duffull SB
    Clin Pharmacokinet; 2013 Jun; 52(6):475-85. PubMed ID: 23483363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis.
    Pan S; Stamp LK; Duffull SB; Barclay ML; Dalrymple JM; Drake J; Zhang M; Korell J
    Clin Pharmacokinet; 2014 Dec; 53(12):1161-70. PubMed ID: 25204405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
    Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types.
    Korell J; Duffull SB; Dalrymple JM; Drake J; Zhang M; Barclay ML; Stamp LK
    Br J Clin Pharmacol; 2014 Mar; 77(3):493-7. PubMed ID: 23844933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
    Dalrymple JM; Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Barclay ML
    Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate Triglutamate as a Determinant of Clinical Response in Mexican Patients With Rheumatoid Arthritis: Pharmacokinetics and Dose Recommendation.
    Huerta-García AP; Rodríguez-Báez AS; Medellín-Garibay SE; Portales-Pérez DP; Martínez-Martínez MU; Abud-Mendoza C; Herrera-Van Oostdam D; Romano-Moreno S; Milán-Segovia RDC
    J Clin Pharmacol; 2021 Aug; 61(8):1118-1130. PubMed ID: 33595870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
    Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplification of a pharmacokinetic model for red blood cell methotrexate disposition.
    Pan S; Korell J; Stamp LK; Duffull SB
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1509-16. PubMed ID: 26407686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis.
    de Rotte MC; de Jong PH; den Boer E; Pluijm SM; Özcan B; Weel AE; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheumatol; 2014 Aug; 66(8):2026-36. PubMed ID: 24692301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
    Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
    Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
    Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
    Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
    Angelis-Stoforidis P; Vajda FJ; Christophidis N
    Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
    Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
    Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
    Dervieux T; Zablocki R; Kremer J
    Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
    den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
    J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.